| Name | Title | Contact Details |
|---|
Child Health Corporation of America (CHCA) is a legacy business alliance of children's hospitals. CHCA children's hospitals represented more than 20,000 physicians, 100,000 employees, $14 billion in revenue and $1.8 billion in overall medical, surgical and pharmaceutical products. CHCA's former Owner Hospitals are North America's leading children's hospitals and are widely known for their excellence in caring for America's children. In 2011, CHCA, the National Association of Children's Hospitals and Related Institutions (NACHRI) and its public policy affiliate National Association of Children's Hospitals (N.A.C.H.) merged to pool our strengths and talents, creating a new organization, the Children’s Hospital Association. We share members, a common board of trustees and new President and CEO Mark Wietecha. As one Association, we will continue to be champions for children’s health.
Simply put, we`re transforming the aging experience so people live longer, healthier lives. By focusing on each person`s abilities and strengths–rather than their limitations–we believe we can impact the healthspan of older adults. Ignited by a passion to inspire older adults to live healthy, meaningful lives, we reach out with our ministries which include: independent and assisted living, rehabilitation, memory support and services including home care, adult day, home-delivered meals, hospice and transportation. As a nonprofit organization guided by Christian compassion, we were founded than 66 years ago as a place for aging Methodist ministers and their spouses to call home. Today, our services are delivered by 1,300 part- and full-time passionate team members throughout the state with a focus on creating healthier and longer lives.
Institute For Safe Medication Practices is a Huntingdon Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The purpose of the Healthcare Foundation is to support the work and mission of Glendale Adventist Medical Center through philanthropy. Foundation responsibilities include the receipt and disbursement of all gifts to the Medical Center, as well as the
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.